Adamas Pharma (ADMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | ADMS | TSHA | PSNL | ||
Company | Adamas Pharma | Taysha Gene Therapies Inc | Personalis Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 8.24 | 2.20 | 3.38 | ||
High | 8.25 | 2.62 | 3.55 | ||
Low | 8.18 | 2.12 | 3.33 | ||
Last | 8.22 | 2.47 | 3.47 | ||
Change | +0.06 | +0.29 | +0.09 | ||
% Change | +0.74% | +13.30% | +2.66% | ||
Volume | 3,151,400 | 9,792,400 | 653,300 | ||
20-Day Average Volume | 834,440 | 7,314,755 | 974,345 | ||
Previous Close | 8.16 | 2.18 | 3.38 | ||
Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
Has Options | No | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 8.16 | 1.87 | 4.57 | ||
20-Day Raw Stochastic | 86.36% | 88.89% | 7.48% | ||
20-Day Relative Strength | 73.46% | 59.96% | 38.51% | ||
Weighted Alpha | +22.54 | -6.40 | -51.73 | ||
Today's Opinion | 100% Buy | 8% Sell | 24% Buy | ||
Previous Opinion | 96% Buy | 40% Sell | 8% Buy | ||
Last Month's Opinion | 100% Buy | 100% Sell | 40% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | +0.86% since 11/16/21 | +19.90% since 11/15/24 | -10.80% since 11/15/24 | ||
Low | 8.15 on 11/17/21 | 1.96 on 11/20/24 | 3.28 on 11/21/24 | ||
High | 8.25 on 11/23/21 | 2.62 on 11/22/24 | 3.88 on 11/18/24 | ||
1-Month | |||||
%Chg | +2.62% since 10/22/21 | +24.12% since 10/22/24 | -26.17% since 10/22/24 | ||
Low | 8.00 on 10/25/21 | 1.19 on 11/05/24 | 3.28 on 11/21/24 | ||
High | 8.25 on 11/23/21 | 2.63 on 11/14/24 | 5.82 on 11/06/24 | ||
3-Month | |||||
%Chg | +77.54% since 08/23/21 | +10.27% since 08/22/24 | -39.23% since 08/22/24 | ||
Low | 4.41 on 08/27/21 | 1.19 on 11/05/24 | 3.28 on 11/21/24 | ||
High | 8.25 on 11/23/21 | 2.63 on 11/14/24 | 6.26 on 08/23/24 | ||
6-Month | |||||
%Chg | +57.47% since 05/21/21 | -16.84% since 05/22/24 | +123.15% since 05/22/24 | ||
Low | 4.02 on 08/16/21 | 1.19 on 11/05/24 | 1.13 on 07/01/24 | ||
High | 8.25 on 11/23/21 | 4.32 on 06/13/24 | 7.20 on 08/16/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 376,369 | 506,209 | 245,149 | ||
Shares Outstanding, K | 45,787 | 204,943 | 70,648 | ||
Annual Sales | 74,460,000 | 15,450,000 | 73,480,000 | ||
Annual Net Income | -57,400,000 | -111,570,000 | -108,300,000 | ||
Last Quarter Sales | 25,900,000 | 1,790,000 | 25,710,000 | ||
Last Quarter Net Income | -19,520,000 | -25,520,000 | -39,090,000 | ||
60-Month Beta | 2.82 | 0.44 | 1.94 | ||
Per-Share Information | |||||
Most Recent Earnings | N/A on 11/10/21 | -0.09 on 11/13/24 | -0.64 on 11/06/24 | ||
Latest Earnings Date | 11/11/21 | 11/13/24 | 11/06/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 31.14 | 0.00 |